In T-cell leukemia, positive staining for RCAS1 expression has been identified in patients whose survival time is short, whereas in B-cell lymphoma, RCAS1 has only been identified in 1 of 8 cases. This evidence concerns the gene EBAG9 and T-cell leukemia.